Paper Details

  1. Home
  2. Paper Details

Is the CHOP regimen a good treatment for advanced CLL? Results from two randomized clinical trials. French Cooperative Group on Chronic Lymphocytic Leukemia.

Author:

Clinical TrialA clinical trial is a planned study conducted on humans to evaluate the efficacy and safety of pharmaceuticals, medical devices, and treatment methods. It aims to explore the possibilities of new treatments and improve the health of patients.
Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.

Overview

This study of 287 stage B and 90 stage C chronic lymphocytic leukemia (CLL) patients found that while CHOP regimen improved treatment response in stage B patients, it did not improve survival compared to chlorambucil plus prednisone. In stage C, no significant difference was found between CHOP and CHOP plus methotrexate in terms of treatment response or survival.
Paper Details　
Original Abstract of the Article :
Between 1985 and 1990, the French Cooperative Group on Chronic Lymphocytic Leukemia (CLL) randomized 287 stage B patients between intermittent chlorambucil plus prednisone (n = 140) or CHOP (n = 147), and 90 stage C patients between CHOP (n = 44) or CHOP plus methotrexate (n = 46). In stage B, altho...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://doi.org/10.3109/10428199409049634

データ提供：米国国立医学図書館（NLM）

CHOP Regimen: A Suitable Treatment for Advanced CLL?

Chronic lymphocytic leukemia (CLL), a type of cancer affecting the blood and bone marrow, presents unique challenges for clinicians. The choice of treatment regimen is crucial for achieving optimal outcomes and improving patient survival. This research sheds light on the effectiveness of the CHOP regimen, a common chemotherapy combination, in treating advanced stages of CLL.

Evaluating CHOP's Effectiveness in Advanced CLL: Results from Clinical Trials

The study examined the outcomes of two randomized clinical trials involving stage B and C CLL patients, comparing the CHOP regimen to other treatment approaches. While CHOP demonstrated improved treatment response in stage B patients, no significant difference in survival was observed between the CHOP and other groups. Similarly, in stage C patients, no significant differences in treatment response or survival were found when comparing CHOP to CHOP plus methotrexate.

Rethinking the Role of CHOP in Advanced CLL

The study's findings raise important questions about the effectiveness of CHOP in advanced CLL patients. The researchers conclude that further investigation is needed to determine the optimal treatment strategies for this challenging disease, particularly in advanced stages.

Dr.Camel's Conclusion

The choice of treatment for advanced CLL is like navigating a treacherous desert path. CHOP has shown some effectiveness, but the journey is far from easy. Further research is essential to uncover the most suitable paths for improving patient outcomes and increasing survival rates in advanced stages of CLL.

Date :
  1. Date Completed 1994-09-29
  2. Date Revised 2019-01-16
Further Info :

Pubmed ID

8069190

DOI: Digital Object Identifier

10.3109/10428199409049634

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.